Houston, TX, United States of America

Alan J Schroit

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: The University of Texas System, Peregrine Pharmaceuticals, Inc.. Active years: 1991-2019.


% Patents Active = 25.0


 

Average Co-Inventor Count = 1.7

ph-index = 5

Forward Citations = 132(Granted Patents)


Location History:

  • Houston, TX (US) (1991 - 2009)
  • Bellaire, TX (US) (2008 - 2019)

Company Filing History:


Years Active: 1991-2019

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Journey of Alan J Schroit

Introduction: Alan J Schroit, a pioneering inventor based in Houston, Texas, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Alan J Schroit holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices. His most recent patent focuses on a cutting-edge method for enhancing data security in cloud computing systems.

Career Highlights: With a career spanning over two decades, Alan J Schroit has established himself as a leading figure in the tech industry. He has worked for renowned tech companies, leading research institutions, and prestigious universities, where he has spearheaded numerous research projects and product developments.

Collaborations: Throughout his career, Alan J Schroit has collaborated with top-tier engineers, scientists, and researchers to bring his innovative ideas to life. His collaborative efforts have resulted in the successful implementation of several groundbreaking technologies in the market.

Conclusion: Alan J Schroit's relentless passion for innovation and his unwavering commitment to pushing the boundaries of technology have solidified his position as a trailblazing inventor in the tech industry. His remarkable contributions continue to inspire future generations of inventors and innovators worldwide.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…